A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer
- 19 May 2015
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 22 (3), 915-922
- https://doi.org/10.1245/s10434-015-4554-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasisGut, 2012
- MicroRNA-200b Regulates Cell Proliferation, Invasion, and Migration by Directly Targeting ZEB2 in Gastric CarcinomaAnnals of Surgical Oncology, 2012
- Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemopreventionWorld Journal of Gastrointestinal Oncology, 2012
- High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancerMedical Oncology, 2011
- Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor PrognosisPLOS ONE, 2011
- MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferationMolecular Cancer, 2010
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAsNature, 2009
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1Nature, 2008
- Epithelial–mesenchymal transitions in development and pathologiesCurrent Opinion in Cell Biology, 2003
- Epithelial–mesenchymal transitions in tumour progressionNature Reviews Cancer, 2002